MIR · Mirion Technologies, Inc.
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
AI Brief
Q2 FY26 earnings call · Jul 29, 2026TL;DR. Mirion reported Q2 revenue up 19.7% to $266.8M with adjusted EBITDA up 27.5% and reaffirmed full-year 2026 guidance, while Q2 orders grew 40% to $291M with backlog up nearly 40% year-over-year, but the medical segment saw end-market guides lowered and a Chinese new-build order was cancelled.
- + Backlog grew nearly 40% year-over-year to over $1.1 billion in Q2 2026.
- + Q2 orders grew 40% to $291M, with nuclear power orders excluding M&A up approximately 50%.
- + Q2 adjusted EBITDA grew 27.5% to $65.3M with margins expanding across both segments.
- + Company reaffirmed full-year 2026 guidance including ~22-24% revenue growth and $285-300M adjusted EBITDA.
- + Raised RTQA full-year organic growth outlook to double digits from prior mid-single-digit-plus guide.
- − Medical segment Q2 organic revenue declined 1%, below prior expectations of low-single-digit growth.
- − Lowered nuclear medicine full-year guide to mid-single digits from prior double-digit guide due to delayed hardware demand.
- − Lowered dosimetry full-year outlook to negative organic growth from prior flat guide.
- − Q2 organic revenue grew only 1%, held back by difficult comps, with first-half organic growth at 2% versus full-year guide of 5-7%.
- − Chinese new-build order cancellation booked in 2019, with potential contract negotiations ahead.
- − Nuclear power Q2 revenue was flat organically as growth in installed base and SMRs was offset by less new build revenue.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Specialty Industrial Machinery — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MIR
this stock
Mirion Technologies, Inc.
|
$3.88B | -39.7% | +7.5% | 155.9 | 15.9% |
|
GEV
GE Vernova Inc.
|
$255.05B | +45.4% | +9.0% | 27.5 | 3.3% |
|
ETN
Eaton Corp plc
|
$170.89B | +34.9% | +10.3% | 44.8 | 2.0% |
|
SMERY
Siemens Energy AG/ADR
|
$139.03B | — | — | — | 0.0% |
|
PH
Parker-Hannifin Corp
|
$123.32B | +8.7% | +18.9% | 34.4 | 1.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MIR | -13.8% | -9.0% | -26.1% | -6.3% | -39.7% |
| SPY | -0.7% | +0.1% | +12.2% | -0.6% | +11.8% |
| vs SPY | -13.1% | -9.1% | -38.3% | -5.7% | -51.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.